Home/Filings/4/0001104659-19-032916
4//SEC Filing

Anstey Michael 4

Accession 0001104659-19-032916

CIK 0001761612other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 9:26 PM ET

Size

17.6 KB

Accession

0001104659-19-032916

Insider Transaction Report

Form 4
Period: 2019-05-28
Transactions
  • Conversion

    Series B2 Preferred Shares

    2019-05-28+229,7410 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
    Ordinary Shares (229,741 underlying)
  • Conversion

    Ordinary Shares

    2019-05-28+1,081,8231,081,823 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
  • Exercise of In-Money

    Ordinary Shares

    2019-05-28+125,5871,207,410 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
  • Conversion

    Ordinary Shares

    2019-05-28+229,7411,437,151 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
  • Purchase

    Ordinary Shares

    2019-05-28$14.00/sh+314,286$4,400,0041,751,437 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
  • Conversion

    Series B1 Preferred Shares

    2019-05-28+1,081,8230 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
    Ordinary Shares (1,081,823 underlying)
  • Exercise of In-Money

    Series B1 Preferred Shares Warrants

    2019-05-28+125,5870 total(indirect: By Cambridge Innovation Capital (Jersey) Limited)
    Ordinary Shares (125,587 underlying)
Footnotes (3)
  • [F1]Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
  • [F2]The shares are held by Cambridge Innovation Capital (Jersey) Limited. The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc.
  • [F3]Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.

Documents

1 file

Issuer

BICYCLE THERAPEUTICS plc

CIK 0001761612

Entity typeother

Related Parties

1
  • filerCIK 0001776856

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 9:26 PM ET
Size
17.6 KB